American Pharmacy News
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • Home
  • »
  • Stories
  • »
  • Industry

MinuteClinic helps fill gap in women's health care

American Pharmacy News Reports | Feb 3, 2017
Some of the services MinuteClinic offers are birth control, HPV vaccines and pregnancy testing.

Access to affordable and dependable health care for women has become  growing issue, and one facility says that it is prepared to play a big role in the solution in making women’s health care more accessible. Read More »

Systech helps drug makers meet serialization deadline

American Pharmacy News Reports | Feb 1, 2017
Serialized by November was designed by Systech to help lower-level and mid-level manufacturer.

Systech International's Serialized by November program helped numerous manufacturers comply with the standards outlined in the Drug Supply Chain Security Act before its deadline. Read More »

Exparel pain reliever receives major endorsement

American Pharmacy News Reports | Jan 31, 2017
The two companies have already begun to promote the drug, marketing it as a non-habit forming pain medication.

DePuy Synthes and Pacira Pharmaceuticals have entered into a partnership to promote pain reliever Exparel. Read More »

Johnson & Johnson purchases Swiss biopharm company

American Pharmacy News Reports | Jan 31, 2017
Johnson & Johnson will hold 16 percent of all shares in R&D NewCo,

Johnson & Johnson has bought the controlling shares of Switzerland-based Actelion, with an immediate finalization of the transaction.  Read More »

Walgreens, Florida Hospital form coordinated care partnership

American Pharmacy News Reports | Jan 29, 2017
Walgreens will manage existing health care clinic locations until this summer's transition.

Florida Hospital and Walgreens have initiated a retail health clinic and pharmacy collaboration to focus on delivering coordinated care and providing greater access to patients across the Tampa region. Read More »

Walgreens to offer FedEx services at pharmacies across the U.S.

American Pharmacy News Reports | Jan 28, 2017
FedEx services are expected to be available in most Walgreens locations by Fall 2018.

Walgreens has a new partnership to offer customers FedEx dropoff and pickup services at Walgreens locations throughout the country. Read More »

PBMI to host Drug Benefit Conference in Florida

American Pharmacy News Reports | Jan 26, 2017
This year's Drug Benefit Conference will be held at the Loews Portofino Bay Hotel at Universal Orlando.

The 22nd PBMI Annual Drug Benefit Conference is set for March 6-8 in Orlando, Florida. Read More »

Major chains fill majority of Medicare Part D prescriptions

American Pharmacy News Reports | Jan 24, 2017
Over 69 percent of elderly patients have enrolled in Medicare Part D plans with major chain pharmacies.

New data from the Centers for Medicare and Medicaid Services shows that major chain pharmacies such as CVS, Walgreens and Walmart account for over 79 percent of Prescription Drug Plans for the elderly. Read More »

CVS Health plans drastic price cut on generic epi-pens

Carol Ostrow | Jan 24, 2017
CVS partnered with Impax to acquire the devices at a lower cost.

Following recent public reaction to the price of epinephrine auto-injector pens, known as “epi-pens,” and the desire for an affordable alternative, CVS Health intends to market authorized generic version two-packs for $109.99 apiece. Read More »

Study shows excessive use of acetaminophen can lead to hearing loss

American Pharmacy News Reports | Jan 21, 2017
The study suggested 15 percent of Americans ages 18 years and older have reported trouble with their hearing.

A recent study has shown that using acetaminophen, an ingredient commonly found in painkillers, over a long period of time leads to an increased risk of hearing loss in adults. Read More »

Gilead Sciences awards $22 million in HIV research funds

American Pharmacy News Reports | Jan 21, 2017
The funds are enough to cover three years’ worth of research.

Gilead Sciences Inc., has awarded more than $22 million in grants to help fund HIV cure programs. Read More »

Study seeks data on generic medication preferences

American Pharmacy News Reports | Jan 21, 2017
The study showed patients have a preference of brand name products.

Results from a November study have raised concerns about how pharmacists substitute generic medications for their name brand counterparts. Read More »

Yet another survey shows U.S. consumer dissatisfaction with big pharma

LocalLabs News Service | Jan 19, 2017

The public relations departments at American pharmaceutical manufacturers can’t be too pleased about the results of a new Harris Poll out this week that shows only nine percent of U.S. consumers believe “pharmaceutical and biotechnology companies put patients over profits.” Read More »

Sanofi, Regeneron ordered to cease Praulent sales

Carol Ostrow | Jan 18, 2017
The permanent injunction against the drug will take effect in 30 days.

Two pharmaceutical giants — Sanofi and Regeneron — face a forced marketing shutdown of a high-priced cholesterol medication following a decision recently handed down by a U.S. District Court in Delaware ruling patent infringement of another medication. Read More »

Mylan purchases popular cold medication Cold-Eeze

American Pharmacy News Reports | Jan 18, 2017
Mylan will have access to all products under the Cold-Eeze brand, which include cough drops, gummines and throat lozenges.

Mylan N.V, a major distributor of over the counter medications, has acquired popular cold medication Cold-Eeze from ProPhase Labs Inc. Read More »

FDA approves Sangamo's drug application for hemophilia A treatment

American Pharmacy News Reports | Jan 18, 2017
The SB-525 gene therapy program was created to help patients with hemophilia A.

The U.S. Food and Drug Administration has approved Sangamo BioSciences Inc.'s Investigational New Drug Application for the SB-525 gene therapy program for patients with hemophilia A. Read More »

Custopharm acquires acetaminophen, testosterone products from Perrigo

American Pharmacy News Reports | Jan 18, 2017
The company plans to market the two products under its new commercial business arm, Leucadia Pharmaceuticals.

Custopharm Inc., a U.S. producer of generic injectable devices, has acquired two Paragraph IV abbreviated new drug application products from Perrigo Co. PLC. Read More »

Amorsa, Janssen partner on nervous system disorder treatment

American Pharmacy News Reports | Jan 14, 2017

Amorsa Therapeutics, a neuropharmaceutical company specializing in treating nervous system disorders, has entered a partnership with Janssen Pharmaceuticals Inc. Read More »

Ionis and Akcea partner with Novartis

American Pharmacy News Reports | Jan 13, 2017

Ionis Pharmaceuticals Inc. and Akcea Therapeutics, an Ionis subsidiary, recently announced a partnership with Novartis to develop and commercialize the drugs AKCEA-APO(a)-LRx and AKCEA-APOCIII-LRx. Read More »

Walgreens, Community Health Network expand partnership

American Pharmacy News Reports | Jan 13, 2017
Nurse practitioners from Community Health Network will staff the 12 clinics.

Expanding their existing relationship, Community Health Network will manage 12 retail health clinics in Walgreens stores across central Indiana. Read More »

  • «
  • 1
  • 2
  • ...
  • 24
  • 25
  • 26 (current)
  • 27
  • 28
  • ...
  • 32
  • 33
  • »
Trending

Brianna Allen, Senior Director of Public Affairs at PhRMA

PhRMA senior director on 340B program: 'Hospitals abuse the program to boost their profits at the expense of patients'

Molly Jenkins, Director of Public Affairs for PhRMA

PhRMA director of public affairs on 340B exploitation: ‘Evidence shows that 340B entities markup medicines by as much 1,000% or more’

Dan DeNeui, CEO of FarmaKeio

Iowa board files charges against FarmaKeio, citing FDA and California actions

Luke Gale, Revenue Cycle Editor, HealthLeaders Media

HealthLeaders editor on 340B: ‘We continue to have serious concerns about persistent and often illegal abuse of 340B’

Lenora S. Newsome PD Chairperson

Potential medication mix-ups between Inflectra and Zymfentra prompt safety warnings

Copyright © 2025 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up